USMed.ai is for sale

USMed.ai is a plain, geographically and categorically precise domain built on one of the fastest-growing, most heavily regulated, and most rapidly adopted technology sectors in American healthcare. This is not an early-stage or speculative category — 75 percent of U.S. health systems now use at least one AI application, up from 59 percent just a year earlier, and 81 percent of U.S. physicians reported using AI tools professionally as of early 2026, according to a Doximity survey, up from just 47 percent nine months prior. The FDA has cleared or authorized more than 1,300 AI-enabled medical devices as of early 2026 — roughly 76 percent of them in radiology — confirming this is a regulation-validated, clinically deployed technology category rather than an unproven one.

The market scale behind this adoption is substantial across every independent estimate, even as the exact figures vary by methodology and scope. U.S.-specific AI-in-healthcare market research places the sector at roughly $52.28 billion in 2026, projected to reach $928.18 billion by 2035 at a compound annual growth rate near 37.66 percent — among the fastest-growing figures tracked in any major technology category. Global estimates, which naturally run somewhat lower given the narrower U.S. focus this domain targets, place the broader AI-in-healthcare market between $37 billion and $51 billion as of 2025-2026, with most forecasts converging on $600 billion or more by the early-to-mid 2030s. AI diagnostics specifically — the largest single application segment — is independently sized at approximately $1.94 billion globally in 2025, growing to $11.82 billion by 2035, with the U.S. portion alone projected to grow nearly sixfold, from $787.64 million to $4.89 billion over the same period.

The financial and clinical case behind this adoption is concrete rather than promotional. Healthcare organizations report an average return of $3.20 for every $1 invested in AI, with payback typically realized within 12 to 18 months, and researchers estimate AI could save the U.S. healthcare system between $200 billion and $360 billion annually through efficiency and diagnostic gains. Clinical accuracy data reinforces the case in specific, measured terms: in a randomized controlled trial spanning more than 105,000 women, AI-assisted mammography achieved 80.5 percent sensitivity compared with 73.8 percent for radiologists working alone, and AI scribe and documentation tools are documented to cut physician charting time by 40 to 45 percent — directly addressing one of medicine's most persistent administrative burdens. AI captured 46 percent of all U.S. healthcare venture investment in 2025, totaling more than $18 billion, confirming sustained, large-scale capital commitment behind this growth.

Unlike a generic "health AI" or "medtech" domain with no geographic anchor, USMed.ai names both the specific, high-regulation U.S. market — where FDA clearance, HIPAA compliance and CMS reimbursement pathways create genuine structural barriers to entry that favor established, credible brands — and the exact technology category driving the sector's growth, on the .ai extension that reinforces rather than dilutes the domain's technical positioning.

Why USMed.ai Stands Out

• Names a U.S. healthcare AI category already used by 75 percent of health systems and 81 percent of physicians, not an early or unproven technology
• Sits inside a U.S. AI-in-healthcare market valued at roughly $52.28 billion in 2026, projected to reach $928.18 billion by 2035 at a 37.66 percent compound annual growth rate
• Backed by FDA regulatory validation, with more than 1,300 AI-enabled medical devices cleared as of early 2026
• Directly relevant to AI diagnostics specifically, the largest single application segment, with the U.S. portion projected to grow nearly sixfold by 2035
• Reflects concrete, independently documented financial returns: $3.20 return per $1 invested, with payback typically within 12 to 18 months
• Supported by specific clinical evidence, including a 105,000-patient trial showing AI-assisted mammography outperforming radiologists on sensitivity
• Captured 46 percent of all U.S. healthcare venture investment in 2025, totaling more than $18 billion, confirming sustained capital commitment
• ".ai" extension reinforces rather than dilutes the domain's technical, AI-specific positioning
• Geographic specificity to the U.S. market signals awareness of the country's distinct FDA, HIPAA and CMS regulatory environment — a genuine structural differentiator from global health-AI domains
• Works equally well as a diagnostics AI company, a clinical documentation and workflow automation platform, a hospital-facing AI vendor, or a broader U.S. health-AI media or investment platform

Ideal Applications

USMed.ai is exceptionally versatile across every context where U.S.-market-specific healthcare AI technology, services, or investment is the core focus.

AI Diagnostics and Medical Imaging

• company and radiology and AI-diagnostic-imaging-platform and AI-diagnostic-imaging-platform-company developers
• platform and mammography and AI-assisted-screening-tool and AI-assisted-screening-tool-platform companies
• company and pathology and AI-image-analysis-detection and AI-image-analysis-detection-company developers
• platform and cardiology and AI-ECG-arrhythmia-detection and AI-ECG-arrhythmia-detection-platform companies
• company and oncology and AI-tumor-detection-screening and AI-tumor-detection-screening-company developers

Clinical Documentation and Physician Workflow AI

• platform and ambient and AI-scribe-clinical-documentation and AI-scribe-clinical-documentation-platform companies
• company and EHR-integration and predictive-clinical-decision-support and predictive-clinical-decision-support-company developers
• platform and administrative and workflow-automation-hospital and workflow-automation-hospital-platform companies
• tool and physician and charting-time-reduction-AI and charting-time-reduction-AI-tool companies

Hospital and Health System AI Infrastructure

• vendor and enterprise and health-system-AI-platform-deployment and health-system-AI-platform-deployment-vendor companies
• company and 400-plus-bed and large-hospital-AI-integration and large-hospital-AI-integration-company providers
• platform and predictive and patient-monitoring-care-management and patient-monitoring-care-management-platform companies
• vendor and population-health and risk-stratification-AI and risk-stratification-AI-vendor companies

Regulatory, Compliance and FDA Clearance Services

• firm and consulting and FDA-AI-medical-device-clearance and FDA-AI-medical-device-clearance-firm companies
• platform and compliance and HIPAA-AI-governance-tool and HIPAA-AI-governance-tool-platform companies
• firm and audit and clinical-AI-safety-validation and clinical-AI-safety-validation-firm companies
• service and reimbursement and CMS-AI-coding-strategy and CMS-AI-coding-strategy-service consultants

Pharmaceutical and Drug Discovery AI

• company and biotech and AI-drug-discovery-platform and AI-drug-discovery-platform-company developers
• firm and pharmaceutical and clinical-trial-AI-optimization and clinical-trial-AI-optimization-firm companies
• platform and research and molecular-design-AI-tool and molecular-design-AI-tool-platform companies

Patient-Facing AI Chatbots and Virtual Care

• platform and telehealth and AI-symptom-triage-chatbot and AI-symptom-triage-chatbot-platform companies
• app and patient and health-information-AI-assistant and health-information-AI-assistant-app companies
• platform and remote-monitoring and AI-alert-care-management and AI-alert-care-management-platform companies

Investment, Research and Healthcare AI Media

• fund and venture-capital and U-S-healthcare-AI-investment and U-S-healthcare-AI-investment-fund managers
• publication and research and healthcare-AI-market-analysis and healthcare-AI-market-analysis-publication media
• firm and equity-research and medtech-AI-sector-coverage and medtech-AI-sector-coverage-firm analysts
• platform and database and FDA-AI-device-clearance-tracker and FDA-AI-device-clearance-tracker-platform companies

Relevant SEO Keywords

• USMed.ai
• US healthcare AI
• AI medical diagnostics market
• FDA AI medical device clearance
• AI clinical documentation scribe
• hospital AI adoption statistics
• AI mammography screening accuracy
• healthcare AI ROI
• AI drug discovery platform
• HIPAA compliant AI healthcare
• digital health venture funding
• AI diagnostic imaging company

These keywords sit directly on top of a large, U.S.-regulated, and independently verified healthcare technology category, matching exactly how hospitals, physicians, investors and vendors already search for and evaluate these tools.

Market Opportunity

• the U.S. AI-in-healthcare market is valued at roughly $52.28 billion in 2026, projected to reach $928.18 billion by 2035 at a 37.66 percent compound annual growth rate, among the fastest-growing figures in any major technology sector
• 75 percent of U.S. health systems now use at least one AI application and 81 percent of U.S. physicians report using AI tools professionally, confirming adoption has moved decisively from experimentation to routine clinical and operational use
• the FDA has cleared more than 1,300 AI-enabled medical devices as of early 2026, with roughly 76 percent in radiology, providing strong regulatory validation and a growing, well-documented pipeline of approved technology
• healthcare organizations report an average $3.20 return for every $1 invested in AI, with payback realized within 12 to 18 months, giving buyers of healthcare AI technology a clear, quantifiable business case
• AI diagnostic imaging specifically is documented to outperform human specialists in controlled studies, including a 105,000-patient trial showing higher mammography sensitivity than radiologists alone
• AI captured 46 percent of all U.S. healthcare venture investment in 2025, totaling more than $18 billion, with Q1 2026 alone recording the strongest quarter for digital health funding since the pandemic peak
• because the domain anchors specifically to the U.S. market, it signals direct relevance to the country's distinct and demanding FDA, HIPAA and CMS regulatory requirements — a genuine differentiator from globally generic health-AI domains

Because U.S. healthcare AI adoption has already crossed from early experimentation into mainstream clinical use across the large majority of health systems and physicians, and because the underlying market is measured in tens of billions of dollars today with a growth trajectory toward hundreds of billions within a decade, USMed.ai names a proven, regulation-validated, and rapidly compounding category rather than a speculative one.

Brand Advantages

• names a U.S. healthcare AI category already used by the large majority of health systems and physicians
• sits inside a market projected to grow at a compound annual rate approaching 38 percent through 2035
• backed by strong FDA regulatory validation, with more than 1,300 cleared AI-enabled medical devices
• directly relevant to AI diagnostics, the category's largest single application segment
• reflects concrete, independently documented financial returns and specific clinical accuracy data
• captured a leading share of all U.S. healthcare venture investment in the most recent full year
• .ai extension reinforces rather than dilutes the domain's technical positioning
• geographic specificity signals direct relevance to U.S.-specific regulatory requirements
• monetization range across diagnostics, clinical documentation, hospital infrastructure, compliance and investment
• equally credible for an enterprise health-AI vendor, a diagnostics startup, or a healthcare AI investment platform

USMed.ai sits at the exact center of a U.S. healthcare technology shift already validated by adoption across three-quarters of health systems and the overwhelming majority of physicians — where the diagnostics startup building the next AI mammography or radiology tool finds a domain that already names the exact FDA-cleared category its product belongs to, the health system procurement officer evaluating vendors against a documented $3.20-per-dollar ROI benchmark finds a brand that speaks directly to the business case driving the purchase decision, the venture investor tracking a sector that captured $18 billion in a single year finds a name aligned precisely with where healthcare capital is already flowing, and the physician whose charting time has been cut by nearly half through AI documentation tools finds that the domain already names, in five characters, the exact transformation already reshaping their daily work.

USMed.ai — Own the exact name of the U.S. healthcare AI category three-quarters of the system already runs on